Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1787, Issue 7, 2009, Pages 794-801

  Penna, Claudia ^a,b   Perrelli, Maria Giulia ^a,b   Raimondo, Stefania ^a   Tullio, Francesca ^a   Merlino, Annalisa ^a   Moro, Francesca ^a   Geuna, Stefano ^a   Mancardi, Daniele ^a   Pagliaro, Pasquale ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Istituto Nazionale Per le Ricerche Cardiovascolari (INRC)   (Italy)

Author keywords

Apoptosis; Cardioprotection; Ischemia reperfusion; Mitochondria

Indexed keywords

CASPASE 3; CONNEXIN 43; CYTOCHROME C; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 60; PROTEIN BCL 2; PROTEIN KINASE PIM 1;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CASPASE 3; CHAPERONIN 60; CONNEXIN 43; CYTOCHROMES C; CYTOSOL; GLYCOGEN SYNTHASE KINASE 3; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERFUSION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-PIM-1; RANDOM ALLOCATION; RATS; RATS, WISTAR;

RATTUS;

EID: 67649274371     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2009.03.013     Document Type: Article

References (56)

1. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H579-H588
2. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of "modified reperfusion" protects themyocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res. 95 (2004) 230-232
3. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44 (2004) 1103-1110
4. Philipp S., Yang X.M., Cui L., Davis A.M., Downey J.M., and Cohen M.V. Postconditioning protects rabbit hearts through a protein kinase C adenosine A2b receptor cascade. Cardiovasc. Res. 70 (2006) 308-314
5. Penna C., Cappello S., Mancardi D., Raimondo S., Rastaldo R., Gattullo D., Losano G., and Pagliaro P. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway, Basic Res. Cardiol 101 (2006) 168-179
6. Penna C., Rastaldo R., Mancardi D., Raimondo S., Cappello S., Gattullo D., Losano G., and Pagliaro P. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K(+) channel and protein kinase C activation, Basic Res. Cardiol 101 (2006) 180-189
7. Bopassa J.C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., and Ovize M. PI3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc. Res. 69 (2006) 178-185
8. Jiang R., Maynard M., Whittaker P., Vinten-Johansen J., and Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1618-H1626
9. Zatta A.J., Kin H., Lee G., Wang N., Jiang R., Lust R., Reeves J.G., Mykytenko J., Guyton R.A., Zhao Z.Q., and Vinten-Johansen J. Infarct sparing effect of myocardial postconditioning is dependent on protein kinase C signaling. Cardiovasc. Res. 70 (2006) 315-324
10. Argaud L., Gateau-Roesch O., Augeul L., Couture-Lepetit E., Loufouat J., Gomez L., Robert D., and Ovize M. Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H386-H391
11. 2+ overload. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H1900-H1908
12. Heusch G., Büchert A., Feldhaus S., and Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res. Cardiol. 101 (2006) 354-356
13. Schulz R., Boengler K., Totzeck A., Luo Y., Garcia-Dorado D., and Heusch G. Connexin 43 in ischemic pre- and postconditioning. Heart Fail. Rev. 12 (2007) 261-266
14. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
15. Crow M.T., Mani K., Nam Y.J., and Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 95 (2004) 957-970
16. Hofstaetter B., Taimor G., Inserte J., Garcia-Dorado D., and Piper H.M. Inhibition of apoptotic responses after ischemic stress in isolated hearts and cardiomyocytes. Basic Res. Cardiol. 97 (2002) 479-488
17. Sun H.Y., Wang N.P., Halkos M., Kerendi F., Kin H., Guyton R.A., Vinten-Johansen J., and Zhao Z.Q. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 11 (2006) 1583-1593
18. Murphy E., and Steenbergen C. Preconditioning: the mitochondrial connection. Ann. Rev. Physiol. 69 (2007) 51-67
19. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83 (2003) 1113-1151
20. Muraski J.A., Rota M., Misao Y., Fransioli J., Cottage C., Gude N., Esposito G., Delucchi F., Arcarese M., Alvarez R., Siddiqi S., Emmanuel G.N., Wu W., Fischer K., Martindale J.J., Glembotski C.C., Leri A., Kajstura J., Magnuson N., Berns A., Beretta R.M., Houser S.R., Schaefer E.M., Anversa P., and Sussman M.A. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat. Med. 13 (2007) 1467-1475
21. Lilly M., and Kraft A. Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Res. 57 (1997) 5348-5355
22. Ahmed N.N., Grimes H.L., Bellacosa A., Chan T.O., and Tsichlis P.N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3627-3632
23. Amaravadi R., and Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115 (2005) 2618-2624
24. Penna C., Mancardi D., Tullio F., and Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res. Cardiol. 103 (2008) 368-377
25. Chen M., He H., Zhan S., Krajewski S., Reed J.C., and Gottlieb R.A. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem. 276 (2001) 30724-30728
26. Boengler K., Konietzka I., Buechert A., Heinen Y., Garcia-Dorado D., Heusch G., and Schulz R. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1764-H1769
27. 2+-induced mitochondrial permeability transition. Cardiovasc Res. 61 (2004) 115-122
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
29. Lilly M., Sandholm J., Cooper J.J., Koskinen P.J., and Kraft A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 18 (1999) 4022-4031
30. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., and Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004) 1535-1549
31. Murphy E., and Steenbergen C. Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin. Ther. Targets 9 (2005) 447-456
32. Murphy E. Inhibit GSK-3beta or there's heartbreak dead ahead. J. Clin. Invest 113 (2004) 1526-1528
33. Gomez L., Paillard M., Thibault H., Derumeaux G., and Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117 (2008) 2761-2768
34. Hansson C.A., Frykman S., Farmery M.R., Tjernberg L.O., Nilsberth C., Pursglove S.E., Ito A., Winblad B., Cowburn R.F., Thyberg J., and Ankarcrona M. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol. Chem. 279 (2004) 51654-51660
35. Ruiz-Meana M., Rodríguez-Sinovas A., Cabestrero A., Boengler K., Heusch G., and Garcia-Dorado D. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc. Res. 77 (2008) 325-333
36. Endo H., Saito A., and Chan P.H. Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochem. Soc. Trans. 34 (2006) 1283-1286
37. Neuzil J., Widén C., Gellert N., Swettenham E., Zobalova R., Dong L.F., Wang X.F., Lidebjer C., Dalen H., Headrick J.P., and Witting P.K. Mitochondria transmit apoptosis signalling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury. Redox Rep. 12 (2007) 148-162
38. Kirshenbaum L.A., and de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96 (1997) 1580-1585
39. Zhu L., Yu Y., Chua B.H., Ho Y.S., and Kuo T.H. Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J. Mol. Cell Cardiol. 33 (2001) 2135-2144
40. Kang P.M., Haunstetter A., Aoki H., Usheva A., and Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 87 (2000) 118-125
41. Penna C., Mancardi D., Raimondo S., Geuna S., and Pagliaro P. The paradigm of postconditioning to protect the heart. J. Cell Mol. Med. 12 (2008) 435-458
42. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., Schulz R., and Heusch G. Ischemic postconditioning in pigs no causal role for RISK activation. Circ. Res. 104 (2008) 15-18
43. Losman J.A., Chen X.P., Vuong B.Q., Fay S., and Rothman P.B. Protein phosphatase 2A regulates the stability of Pim protein kinases. J. Biol. Chem. 278 (2003) 4800-4805
44. Ladilov Y., Maxeiner H., Wolf C., Schäfer C., Meuter K., and Piper H.M. Role of protein phosphatases in hypoxic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1092-H1098
45. Fenton R.A., Dickson E.W., and Dobson Jr. J.G. Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart. Life Sci. 77 (2005) 3375-3388
46. Feng J., Lucchinetti E., Ahuja P., Pasch T., Perriard J.C., and Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 103 (2005) 987-995
47. Nishino Y., Webb I.G., Davidson S.M., Ahmed A.I., Clark J.E., Jacquet S., Shah A.M., Miura T., Yellon D.M., Avkiran M., and Marber M.S. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ. Res. 103 (2008) 307-314
48. Linseman D.A., Butts B.D., Precht T.A., Phelps R.A., Le S.S., Laessig T.A., Bouchard R.J., Florez-McClure M.L., and Heidenreich K.A. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J. Neurosci. 24 (2004) 9993-10002
49. Kuribayashi K., Mayes P.A., and El-Deiry W.S. What are caspases 3 and 7 doing upstream of the mitochondria?. Cancer Biol. Ther. 5 (2006) 763-765
50. Boengler K., Schulz R., and Heusch G. Connexin 43 signalling and cardioprotection. Heart 92 (2006) 1724-1727
51. Heinzel F.R., Luo Y., Li X., Boengler K., Buechert A., García-Dorado D., Di Lisa F., Schulz R., and Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ. Res. 97 (2005) 583-586
52. Boengler K., Dodoni G., Rodriguez-Sinovas A., Cabestrero A., Ruiz-Meana M., Gres P., Konietzka I., Lopez-Iglesias C., Garcia-Dorado D., Di Lisa F., Heusch G., and Schulz R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc. Res. 67 (2005) 234-244
53. Tsutsumi Y.M., Yokoyama T., Horikawa Y., Roth D.M., and Patel H.H. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 81 (2007) 1223-1227
54. Penna C., Mancardi D., Rastaldo R., Losano G., and Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc. Res. 75 (2007) 168-177
55. Goubaeva F., Mikami M., Giardina S., Ding B., Abe J., and Yang J. Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem. Biophys. Res. Commun. 352 (2007) 97-103
56. Halestrap A.P. Mitochondria and preconditioning: a connexin connection?. Circ. Res. 99 (2006) 10-12